FDA "B" List For Cosmetics Priorities Includes Adverse Event Monitoring

Office of Cosmetics & Colors Director John Bailey, PhD, included cosmetics adverse reaction monitoring as part of the office's "B" List for priority activities in 1999. Bailey spoke during a Cosmetic, Toiletry Fragrance Association-sponsored "Meet the Regulators" conference in Bethesda, Md. Feb. 2.